Age-related deterioration in arterial structure and function in postmenopausal women: Impact of hormone replacement therapy

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 7, 1998, Pages 1149-1156

  McGrath, Barry P ^a   Liang, Yu Lu ^a   Teede, Helena ^a   Shiel, Louise M ^a   Cameron, James D ^b   Dart, Anthony ^c  

^a MONASH UNIVERSITY   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Arterial compliance; Carotid intima media thickness; Estrogen; Postmenopausal; Progestins

Indexed keywords

CHOLESTEROL; CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTERY COMPLIANCE; ARTERY MEDIA; ARTICLE; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; IMAGING; INTIMA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; SMOKING; STRUCTURE ANALYSIS;

EID: 0031927190     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.7.1149     Document Type: Article

References (15)

1. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 1993;328: 1069-1079.
2. Ross RK, Paganini HA, Mack TM, Arthur M, Henderson BE. Menopausal estrogen therapy and protection from death from ischaemic heart disease. Lancet. 1981;160:858-860.
3. Ross PK, Paganini-Hill A, Mack T, Henderson B. Cardiovascular benefits of estrogen replacement therapy. Am J Obstet Gynecol. 1989;160: 1301-1306.
4. Wolf PH, Madans JH, Finucane FF, Higgins M, Kleinman JC. Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort. Am J Obstet Gynecol. 1991;164:489-494.
5. Stampfer MJ, Colditz GA, Willett WC. Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med. 1991;325:756-762.
6. Rosano GMC, Sarrel PNM, Poole-Wilson PA, Collins P. Beneficial effects of estrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet. 1993:342:133-136.
7. Punnonen R, Jokela H, Heinonen PK, Aine R, Dastidar P. Hormone replacement therapy and atherosclerosis. J Reprod Med. 1995;40: 267-272.
8. Sack MN, Rader DJ, Cannon RO. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet. 1994;343: 267-270.
9. Adams MR, Kaplan JR, Manuck SB. Inhibition of coronary artery atherosclerosis by 17β-estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis. 1990;10:1051-1057.
10. Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW. Oestrodiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol. 1993;109:612-617.
11. Sulistiyani, Adelman SJ, Chandrasekaran A, Jayo J. St Clair RW. Effect of 17α-dihydroequilin sulfate, a conjugated equine estrogen, and ethynyl estradiol on atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vase Biol. 1995;15:837-846.
12. Williams JK, Anthony MS, Honore EK, Herrington DM, Morgan TM. Regression of atherosclerosis in female monkeys. Arterioscler Thromb Vasc Biol. 1995;15:827-836.
13. Kushwaha RS, Lewis DS, Carey D, McGill HC. Effects of estrogen and progesterone on plasma lipoproteins and experimental atherosclerosis in the baboon. Arterioscler Thromb. 1991;11:23-31.
14. Bonithon-Kopp C. Prevalence of and risk factors for intima-media thickening: a literature review. In: Touboul P-J, Grouse JR, eds. Intima-Media Thickness and Atherosclerosis: Predicting the Risk? New York, NY: Parthenon Publishing Group; 1997:27-44.
15. Crouse JR. Association of arterial wall thickening and coronary disease. In: Touboul P-J, Crouse JR, eds. Intima-Media Thickness and Atherosclerosis: Predicting the Risk? New York, NY: Parthenon Publishing Group; 1997:105-115.